Strides Shasun to acquire controlling stake in South Africa’s Trinity Pharma

Indian-based drugs maker Strides Shasun Ltd has agreed to acquire a 55% stake in South Africa-based Trinity Pharma Proprietary Ltd for $4.3 million in an all-cash deal. Strides Shasun announced in a stock exchange disclosure that the firm will acquire the controlling stake in Trinity Pharma through its wholly owned subsidiary Strides Pharma Asia Pte. […]

Read more

Gilead To License Generic Production of Bictegravir To MPP & Four Manufacturers

Gilead Sciences, Inc. has announced a new licensing agreement with the Medicines Patent Pool, a United Nations-backed public health organization, to expand access to bictegravir upon regulatory approval in the U.S. Through the agreement, the Medicines Patent Pool can sub-license rights to bictegravir to generic drug companies in India, China and South Africa to manufacture […]

Read more

The Red Cross and mPharma join forces to improve access to affordable medication in Zimbabwe

Thousands of Zimbabweans will soon have access to affordable essential medical drugs thanks to a new partnership between the Red Cross and mPharma. The partnership will create a network of pharmacies linked to Red Cross health clinics and other community-based health facilities, providing the lowest price for medical drugs in Zimbabwe. The first two locations […]

Read more

Adcock Ingram to acquire Genop Holdings

South African drugmaker Adcock Ingram have announced the acquisition of Genop Holdings suppliers of; contact lenses, surgical and skincare products supplier Genop Holdings, a deal that allows Adcock to add a company with 400 million rand ($31 million) in annual sales to their holdings. Adcock did not disclose the financial details of the deal, which […]

Read more

UNAIDS asks Chinese to boost drug production for Africa

The head of the Joint United Nations Programme on HIV and AIDS has called on China to boost prevention and control in Africa by encouraging the country’s drugmakers to open production hubs on the continent. Michel Sidibe, executive director of UNAIDS, said the central government should use the China-Africa Development Fund to mobilize key pharmaceutical […]

Read more

Hundreds of tonnes of illicit medicines seized in African operation

More than 420 tonnes of illicit pharmaceutical and medical products have been seized in an operation in West Africa coordinated by INTERPOL. Operation Heera (15 May – 17 June) involved some 1,150 law enforcement officials from police, customs and health regulatory agencies in seven countries – Benin, Burkina Faso, Côte d’Ivoire, Mali, Niger, Nigeria and […]

Read more

Zimbabwe, South Africa sign health co-operation deal

ZIMBABWE and South Africa have this week, signed a five-year health co-operation deal to jointly fight common diseases such as malaria, tuberculosis and HIV and Aids, among others. The agreement, signed by Health minister David Parirenyatwa and his South African counterpart Aaron Motsoaledi on the sidelines of the World Health Organisation (WHO) regional conference for […]

Read more

Adcock Ingram Announces Positive Year-End Results

An exceptional increase in trading profit was the highlight announced by Adcock Ingram today when the Group’s year-end results were published. Despite the continuing economic downturn and pressure on consumer spending, a satisfying trading performance was achieved with improved performances across all commercial divisions of the business. “The positive results are a reflection of our […]

Read more

Frost & Sullivan: Africa still has ample opportunity for growth, despite current challenges

Over 200 African business leaders met in Cape Town for GIL 2017: Africa – the Growth, Innovation and Leadership summit It has been noted that, despite local challenges and global volatility, Africa still presents ample opportunity for growth. The digital sphere continues to shape and disrupt a number of industry sectors and, as a result, […]

Read more

Novartis, MMV begin patient trial of antimalarial compound in Africa

Novartis and Medicines for Malaria Venture (MMV) have started a patient trial of antimalarial compound, KAF156, in Africa. KAF156, which belongs to the class of the imidazolopiperazines, is a next-generation antimalarial compound that holds capability to treat drug-resistant strains of the malaria parasite. The trial was designed to test the efficacy of KAF156 in combination […]

Read more

U.S. Pharmaceutical Firm Sets Up First Subsidiary in Rwanda

L.E.A.F. Pharmaceuticals LLC, a US-based global pharmaceutical company, has announced it is establishing a subsidiary in Rwanda, headquartered in Kigali. The parent firm is located in Valley Forge, Pennsylvania, USA. Its stated mission is to discover, develop and commercialise innovative and safe therapies for cancer. The company expects to focus on establishing Rwanda as a […]

Read more


You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

SAPHEX 2018 will use the information you provide on this form to be in touch with you and to provide updates on our pan-African events & the latest news from pharmaceutical sector in Africa.